DuPont de Nemours (DD) 8-KAnnounces Preliminary Fourth Quarter and Full Year 2020 Total Company and N&B Segment Results

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 26, 2021

DuPont de Nemours, Inc.

(Exact name of registrant as specified in its charter)

(302) 774-3034

(Registrant’s Telephone Number, Including Area Code)

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Section 2 - Financial Information

On January 26, 2021, DuPont de Nemours, Inc. issued a press release, attached as Exhibit 99.1, and incorporated herein by reference, announcing preliminary fourth quarter and preliminary full year 2020 results for DuPont and for its Nutrition & Biosciences segment.

The information contained in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this report shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.

Notwithstanding the foregoing, the information contained in this report, including Exhibit 99.1 attached hereto, is incorporated by reference into the Registration Statement on Form S-1/S-4 of Nutrition & Biosciences, Inc. (Registration Number 333-238089) and the prospectus, dated December 31, 2020, contained therein, and into the Registration Statement on Form S-4 of International Flavors & Fragrances Inc. (Registration Number 333-238072) and the prospectus, dated December 31, 2020, contained therein.

Section 9 - Financial Statements and Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.